EdU assays revealed that the proportion of new cells in the C-MYC over-expression group obviously increased, while this proportion correspondingly decreased after NCOA4 over-expression in ovarian cancer cells (Figure 3D–E). The gene discussed is NCOA4; the disease is ovarian carcinoma.